Exagen (XGN) said Monday it agreed to a term loan credit facility of up to $75 million with Perceptive Advisors.
Exagen said the first $25 million tranche was funded at close and used to retire its term debt facility with Innovatus Capital Partners.
The second and third tranches of $10 million each are available through Mar. 31, 2026, and Dec. 31, 2026, respectively, subject to achievement of certain revenue milestones, the company said.
The company added that a business development tranche of $30 million is available through Mar. 31, 2027, and will be funded at Perceptive's discretion.
Price: 6.31, Change: +0.10, Percent Change: +1.61
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.